The abstract is read at the publisher; the summary is JClub's.
Daily tadalafil treatment in bleomycin- or paraquat-induced rat pulmonary fibrosis attenuates fibrotic progression and lung injury, including when given at advanced disease stages.
- Why it matters: Pulmonary fibrosis has limited therapies, and epithelial-mesenchymal transition (EMT) is a key pathological step; the cGMP mechanism, especially for EMT, remains unclear.
- What they did: In two rat PF models, tadalafil was administered to test antifibrotic efficacy, while pathway work assessed cGMP/PKG signaling, TGF-β/Smad activity, EMT markers, and HDAC2 regulation.
- The result: Tadalafil suppressed TGF-β/Smad signaling and EMT via cGMP/PKG, with preliminary PKG-dependent HDAC2 down-regulation and increased acetylated histones; HDAC2 knockdown or inhibition mimicked, but HDAC2 over-expression negated, tadalafil’s EMT effects.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.